Prospera Financial Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.89M Buy
112,958
+2,275
+2% +$159K 0.15% 150
2025
Q1
$8.14M Buy
110,683
+8,124
+8% +$597K 0.19% 124
2024
Q4
$6.72M Sell
102,559
-688
-0.7% -$45.1K 0.16% 144
2024
Q3
$8.04M Buy
103,247
+9,080
+10% +$707K 0.21% 107
2024
Q2
$7.34M Buy
94,167
+27,416
+41% +$2.14M 0.2% 108
2024
Q1
$4.52M Buy
66,751
+8,420
+14% +$571K 0.13% 164
2023
Q4
$3.93M Buy
58,331
+40,430
+226% +$2.72M 0.13% 178
2023
Q3
$1.21M Buy
17,901
+2,231
+14% +$151K 0.05% 381
2023
Q2
$1.12M Sell
15,670
-84,316
-84% -$6.04M 0.04% 389
2023
Q1
$6.94M Sell
99,986
-3,134
-3% -$218K 0.29% 87
2022
Q4
$6.99M Sell
103,120
-39,015
-27% -$2.65M 0.35% 70
2022
Q3
$7.8M Buy
142,135
+3,157
+2% +$173K 0.41% 42
2022
Q2
$9.18M Buy
138,978
+35,086
+34% +$2.32M 0.47% 34
2022
Q1
$6.89M Buy
103,892
+95,776
+1,180% +$6.35M 0.29% 69
2021
Q4
$473K Sell
8,116
-3,003
-27% -$175K 0.02% 588
2021
Q3
$668K Buy
11,119
+4,113
+59% +$247K 0.03% 455
2021
Q2
$421K Sell
7,006
-99
-1% -$5.95K 0.02% 570
2021
Q1
$354K Sell
7,105
-476
-6% -$23.7K 0.02% 574
2020
Q4
$378K Buy
7,581
+5,037
+198% +$251K 0.03% 476
2020
Q3
$139K Sell
2,544
-4,357
-63% -$238K 0.05% 318
2020
Q2
$365K Buy
6,901
+106
+2% +$5.61K 0.03% 406
2020
Q1
$303K Sell
6,795
-35
-0.5% -$1.56K 0.03% 393
2019
Q4
$341K Sell
6,830
-12
-0.2% -$599 0.03% 454
2019
Q3
$305K Buy
6,842
+623
+10% +$27.8K 0.03% 427
2019
Q2
$256K Sell
6,219
-505
-8% -$20.8K 0.03% 440
2019
Q1
$275K Buy
+6,724
New +$275K 0.09% 259
2015
Q1
Sell
-19,220
Closed -$676K 322
2014
Q4
$676K Buy
19,220
+360
+2% +$12.7K 0.17% 99
2014
Q3
$674K Buy
18,860
+954
+5% +$34.1K 0.18% 86
2014
Q2
$665K Buy
17,906
+7,280
+69% +$270K 0.18% 91
2014
Q1
$345K Buy
+10,626
New +$345K 0.11% 143